Skip to content
Open access

Insights Into Genomic Drivers, Transcriptomic Heterogeneity, and Therapeutic Vulnerabilities From Novel Mesothelioma Cell Lines

Aug 2026 · Thoracic Cancer · Vol 17 · 0 citations · 25 references
Medicine

Abstract

Pleural mesothelioma (PM) is an aggressive cancer with limited therapeutic options and poor prognosis, necessitating comprehensive model systems for mechanistic studies and drug discovery.

Read PDF

Similar papers

Sep 2026

Beyond Major Pathologic Response in Lung Cancer: Biomarkers Predict Outcomes.

Neoadjuvant chemoimmunotherapy improves outcomes in resectable non-small cell lung cancer, yet pathologic response incompletely predicts durability of benefit. Spatial profiling using resected tumors and lymph nodes revealed distinct immune subtypes and identified a gene signature associated with improved outcomes, pro...

V. Wang, Natalie M. Ward, J. Kratz · 0 citations
Editorial Open access Sep 2026

Cytopathology as a bridge between bench and bedside in mouse cancer models

Experimental oncology has relied on murine models for decades to explore carcinogenic pathways, study tumor microenvironments

Barnali Dolui, Banani Majumdar, Anupam Basu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.